The Association Between Race and Treatment Regret Among Men with Recurrent Prostate Cancer

Overview

Journal Prostate Cancer Prostatic Dis

Specialties Oncology
Urology

Date 2014 Oct 29

PMID 25348256

Citations 9

Authors

B A Mahal

M-H Chen

C L Bennett

M W Kattan

O Sartor

K Stein

A V DAmico

P L Nguyen

Affiliations

Soon will be listed here.

Abstract

Background: To examine the impact of race on treatment regret among men with recurrent prostate cancer after surgery or radiation.

Methods: The prospective Comprehensive, Observational, Multicenter, Prostate Adenocarcinoma (COMPARE) registry was used to study a cohort of 484 men with biochemically recurrent prostate cancer after radical prostatectomy, external beam radiation or brachytherapy. Multivariable logistic regression was used to model the association between race and treatment regret and to determine whether there was an interaction between race and sexual problems after treatment with regards to treatment regret.

Results: Black men (N=78) were significantly more likely to have treatment regret when compared with non-black men (N=406; 21.8% versus 12.6%) on univariable analysis (odds ratio (OR) 1.94; 95% confidence interval 1.05-3.56; P=0.03). On multivariable analysis, black race trended towards but was no longer significantly associated with an increase in treatment regret (adjusted OR (AOR) 1.84 (0.95-3.58); P=0.071). There was an interaction between race and sexual problems after treatment (Pinteraction=0.02) such that among those without sexual problems, black men had more treatment regret than non-black men (26.7% versus 8.4%: AOR 4.68 (1.73-12.63); P=0.002), whereas among those with sexual problems, there was no difference in treatment regret between black and non-black men (18.8% versus 17.3%: AOR 1.04 (0.44-2.46); P=0.93).

Conclusions: Among men with recurrent prostate cancer after surgery or radiation, black men were nearly twice as likely to experience treatment regret. Treating physicians should ensure that patients are fully apprised of the pros and cons of all treatment options to reduce the risk of subsequent regret.

Citing Articles

Decision regret after prostate biopsy for prostate cancer diagnosis: a Korean multicenter cohort study.

Kim H, Bang W, Shim M, Oh C, Cho S, Chung M BMC Public Health. 2024; 24(1):1725.

PMID: 38943112 PMC: 11212167. DOI: 10.1186/s12889-024-19179-1.

Trajectory of Depression among Prostate Cancer Patients: A Secondary Analysis of a Randomized Controlled Trial.

Chhatre S, Gallo J, Guzzo T, Morales K, Newman D, Vapiwala N Cancers (Basel). 2023; 15(7).

PMID: 37046786 PMC: 10092991. DOI: 10.3390/cancers15072124.

Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial.

Berry D, Hong F, Blonquist T, Halpenny B, Xiong N, Filson C Urol Oncol. 2020; 39(8):493.e9-493.e15.

PMID: 33353864 PMC: 8213859. DOI: 10.1016/j.urolonc.2020.11.038.

Factors influencing chemotherapy knowledge in women with breast cancer.

Parker P, Heiney S, Adams S, Friedman D, Dawson R Appl Nurs Res. 2020; 56:151335.

PMID: 32739071 PMC: 7722178. DOI: 10.1016/j.apnr.2020.151335.

Examining the association of health literacy and numeracy with prostate-related knowledge and prostate cancer treatment regret.

Joyce D, Heslop D, Umoh J, Brown S, Robles J, Wallston K Urol Oncol. 2020; 38(8):682.e11-682.e19.

PMID: 32448502 PMC: 10129910. DOI: 10.1016/j.urolonc.2020.04.007.

References

Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A . Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol. 2009; 28(1):126-31. DOI: 10.1200/JCO.2009.24.2180. View

Moore A, Hamilton J, Knafl G, Godley P, Carpenter W, Bensen J . The influence of mistrust, racism, religious participation, and access to care on patient satisfaction for African American men: the North Carolina-Louisiana Prostate Cancer Project. J Natl Med Assoc. 2013; 105(1):59-68. DOI: 10.1016/s0027-9684(15)30086-9. View

Forrester-Anderson I . Prostate cancer screening perceptions, knowledge and behaviors among African American men: focus group findings. J Health Care Poor Underserved. 2005; 16(4 Suppl A):22-30. DOI: 10.1353/hpu.2005.0122. View

Sanda M, Dunn R, Michalski J, Sandler H, Northouse L, Hembroff L . Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008; 358(12):1250-61. DOI: 10.1056/NEJMoa074311. View

Clarke-Tasker V, Wade R . What we thought we knew: African American males' perceptions of prostate cancer and screening methods. ABNF J. 2002; 13(3):56-60. View

Diefenbach M, Mohamed N . Regret of treatment decision and its association with disease-specific quality of life following prostate cancer treatment. Cancer Invest. 2007; 25(6):449-57. DOI: 10.1080/07357900701359460. View

Feldman-Stewart D, Tong C, Siemens R, Alibhai S, Pickles T, Robinson J . The impact of explicit values clarification exercises in a patient decision aid emerges after the decision is actually made: evidence from a randomized controlled trial. Med Decis Making. 2012; 32(4):616-26. DOI: 10.1177/0272989X11434601. View

Befort C, Zelefsky M, Scardino P, Borrayo E, Giesler R, Kattan M . A measure of health-related quality of life among patients with localized prostate cancer: results from ongoing scale development. Clin Prostate Cancer. 2005; 4(2):100-8. DOI: 10.3816/cgc.2005.n.017. View

Schroeck F, Krupski T, Sun L, Albala D, Price M, Polascik T . Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy. Eur Urol. 2008; 54(4):785-93. DOI: 10.1016/j.eururo.2008.06.063. View

10.

Woods V, Montgomery S, Belliard J, Ramirez-Johnson J, Wilson C . Culture, black men, and prostate cancer: what is reality?. Cancer Control. 2004; 11(6):388-96. PMC: 4654412. DOI: 10.1177/107327480401100606. View

11.

Stokes W, Hendrix L, Royce T, Allen I, Godley P, Wang A . Racial differences in time from prostate cancer diagnosis to treatment initiation: a population-based study. Cancer. 2013; 119(13):2486-93. DOI: 10.1002/cncr.27975. View

12.

Underwood W, De Monner S, Ubel P, Fagerlin A, Sanda M, Wei J . Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol. 2004; 171(4):1504-7. DOI: 10.1097/01.ju.0000118907.64125.e0. View

13.

Clark J, Wray N, Ashton C . Living with treatment decisions: regrets and quality of life among men treated for metastatic prostate cancer. J Clin Oncol. 2001; 19(1):72-80. DOI: 10.1200/JCO.2001.19.1.72. View

14.

Presley C, Raldow A, Cramer L, Soulos P, Long J, Yu J . A new approach to understanding racial disparities in prostate cancer treatment. J Geriatr Oncol. 2013; 4(1):1-8. PMC: 3697868. DOI: 10.1016/j.jgo.2012.07.005. View

15.

Collingwood S, McBride R, Leapman M, Hobbs A, Kwon Y, Stensland K . Decisional regret after robotic-assisted laparoscopic prostatectomy is higher in African American men. Urol Oncol. 2014; 32(4):419-25. DOI: 10.1016/j.urolonc.2013.10.011. View

16.

Eggener S, Scardino P, Walsh P, Han M, Partin A, Trock B . Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol. 2011; 185(3):869-75. PMC: 4058776. DOI: 10.1016/j.juro.2010.10.057. View

17.

Gwede C, Pow-Sang J, Seigne J, Heysek R, Helal M, Shade K . Treatment decision-making strategies and influences in patients with localized prostate carcinoma. Cancer. 2005; 104(7):1381-90. DOI: 10.1002/cncr.21330. View

18.

Winterich J, Grzywacz J, Quandt S, Clark P, Miller D, Acuna J . Men's knowledge and beliefs about prostate cancer: education, race, and screening status. Ethn Dis. 2009; 19(2):199-203. PMC: 2699598. View

19.

Ratcliff C, Cohen L, Pettaway C, Parker P . Treatment regret and quality of life following radical prostatectomy. Support Care Cancer. 2013; 21(12):3337-43. PMC: 3823814. DOI: 10.1007/s00520-013-1906-4. View

20.

Nguyen P, Chen M, Hoffman K, Chen R, Hu J, Bennett C . Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. BJU Int. 2011; 110(2):201-5. DOI: 10.1111/j.1464-410X.2011.10709.x. View